weight-loss

The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare…

Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…

Doctors have warned of the risk of overuse and misuse, cautioning that patients will see such medications as an easy, quick fix,…

The move taps into surging demand for appetite-suppressing GLP-1 agonists, set against ongoing shortages of newer weight-loss…

16 new weight-loss drugs anticipated by 2029, potentially expanding the market to $200 billion by 2031, as competition heats up

Regulator highlights risks of dosing errors and adverse events, urges healthcare providers to ensure correct syringe use and…

The warnings were issued on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug Ozempic…

The drug, semaglutide, works by hijacking the body's own appetite-regulating system in the brain leading to reduced hunger and…